Arrowhead Pharmaceuticals Inc (ARWR)
24.97
-0.21
(-0.83%)
USD |
NASDAQ |
May 07, 16:00
24.97
0.00 (0.00%)
After-Hours: 16:23
Arrowhead Pharmaceuticals Cash from Investing (Quarterly): 64.84M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 64.84M |
| September 30, 2023 | 30.51M |
| June 30, 2023 | -9.905M |
| March 31, 2023 | -36.06M |
| December 31, 2022 | -80.69M |
| September 30, 2022 | 36.44M |
| June 30, 2022 | 61.28M |
| March 31, 2022 | -69.76M |
| December 31, 2021 | -33.38M |
| September 30, 2021 | -118.24M |
| June 30, 2021 | -19.54M |
| March 31, 2021 | -34.05M |
| December 31, 2020 | 30.16M |
| September 30, 2020 | -65.90M |
| June 30, 2020 | -6.034M |
| March 31, 2020 | -178.13M |
| December 31, 2019 | 9.28M |
| September 30, 2019 | 16.83M |
| June 30, 2019 | 14.40M |
| March 31, 2019 | -11.22M |
| December 31, 2018 | -67.76M |
| September 30, 2018 | 3.247M |
| June 30, 2018 | -28.85M |
| March 31, 2018 | 16.82M |
| December 31, 2017 | 1.357M |
| Date | Value |
|---|---|
| September 30, 2017 | -4.219M |
| June 30, 2017 | -12.93M |
| March 31, 2017 | -26.20M |
| December 31, 2016 | -5.297M |
| September 30, 2016 | -1.712M |
| June 30, 2016 | 9.461M |
| March 31, 2016 | 3.106M |
| December 31, 2015 | 2.593M |
| September 30, 2015 | 5.845M |
| June 30, 2015 | 3.977M |
| March 31, 2015 | 8.799M |
| December 31, 2014 | -4.500M |
| September 30, 2014 | 4.545M |
| June 30, 2014 | 0.9364M |
| March 31, 2014 | -26.82M |
| December 31, 2013 | -15.15M |
| September 30, 2013 | -6.521M |
| June 30, 2013 | -4.258M |
| March 31, 2013 | 1.146M |
| December 31, 2012 | 0.112M |
| September 30, 2012 | 0.1784M |
| June 30, 2012 | -0.0761M |
| March 31, 2012 | -0.2013M |
| December 31, 2011 | 0.5396M |
| September 30, 2011 | 0.4044M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-178.13M
Minimum
Mar 2020
64.84M
Maximum
Dec 2023
-20.42M
Average
-9.905M
Median
Jun 2023
Cash from Investing (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | -362.12M |
| Viking Therapeutics Inc | -459.79M |
| Akero Therapeutics Inc | 12.79M |
| 89bio Inc | -63.64M |
| Sagimet Biosciences Inc | -19.62M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -117.84M |
| Cash from Financing (Quarterly) | 0.267M |
| Free Cash Flow | -402.70M |
| Free Cash Flow Per Share (Quarterly) | -1.736 |
| Free Cash Flow to Equity (Quarterly) | -186.50M |
| Free Cash Flow to Firm (Quarterly) | -183.99M |
| Free Cash Flow Yield | -15.01% |